Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 39, Issue 3, 2009, Pages 304-309

  Liu, Xiao Xuan ^a   Zhang, Jun ^a   Zheng, Ju Yang ^a   Zhang, Shuo ^a   Xu, Ying Sheng ^a   Kang, De Xuan ^a   Fan, Dong Sheng ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

ALS functional rating score; Amyotrophic lateral sclerosis; Compound muscle action potential amplitude; Forced vital capacity; Motor unit number estimates; Progression rate

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; PRIORITY JOURNAL;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 62849110313     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21144     Document Type: Article

References (21)

1. ALS CNTF Treatment study (ACTs) Phase III Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTs) Phase I-II Study Group. Arch Neurol 1996;53:141-147.
2. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-333.
3. Armon C, Brandstater ME. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve 1999;22:1571-1575.
4. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
5. Brooks BR, Miller RG, Swash M, Munsat TL. For the World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-300.
6. Cudkowicz M, Qureshi M, Shefner J. Measures and markers in amyotrophic lateral sclerois. NeuroRx 2004;1:273-283.
7. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-1063.
8. de-Carvalho M, Chio A, Dengler R, Hecht M, Weber M, Swash M. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:17-28
9. Felice KJ. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve 1997;20:179-185.
10. Heiman-Patterson TD, Miller RG. NIPPV, a treatment for ALS whose time has come. Neurology 2006;67:736-737.
11. Kelly JJ, Thibodeau L, Andres PL, Finison LJ. Use of electro-physiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve 1990;13:471-479.
12. Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Noninvasive positive-pressure ventilation in ALS: predictors of tolerande and survival. Neurology 2006;67:761-765.
13. McComas AJ, Fawcett PRW, Campbell MJ. Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry 1971;34:121-131.
14. Miller RG, Moore DH, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001;56:843-848.
15. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007;369:2031-2041.
16. Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol 2005;18:712-719.
17. Shefner JM. Motor unit number estimation in human neurological diseases and animal models. Clin Neurophysiol 2001;112:955-964.
18. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, et al. A clinical trial of creatine in ALS. Neurology 2004;63:1656-1661.
19. Shefner JM, Cudkowicz ME, Zhang H. The use of statistical motor unit number estimate in a multicenter clinical trial. Muscle Nerve 2004;30:463-469.
20. Wang FC, Bouquiau O, De Pasqua V. Changes in motor unit numbers in patients with ALS: a longitudinal study using the adapted multiple point stimulation method. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3:31-38.
21. Yuen E, Olney R. Longitudinal study of fibre density and motor unit estimates in patients with amytrophic lateral sclerosis. Neurology 1997;49:573-578.